Blood test monitoring of immunomodulatory therapy in inflammatory disease

BMJ. 2021 Feb 8:372:n159. doi: 10.1136/bmj.n159.

Authors

Nathaniel J Spencer¹, Anthony A Fryer^{1

2}, Adam D Farmer^{2

3}, Christopher J Duff^{4

2}

Affiliations

¹ Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
² School of Medicine, Keele University, Stoke-on-Trent, UK.
³ Department of Gastroenterology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
⁴ Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK chris.duff@uhnm.nhs.uk.

PMID: 33558310
DOI: 10.1136/bmj.n159

No abstract available

Publication types

Review

MeSH terms

COVID-19
Drug Monitoring / standards*
General Practice / methods*
Hematologic Tests / standards
Humans
Immunologic Factors / therapeutic use*
Immunomodulation*

Substances

Immunologic Factors